Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Connection

Search Results to Peter A Forsberg

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Forsberg, Peter

Item TypeName
Concept Multiple Myeloma
Academic Article Pomalidomide in the treatment of relapsed multiple myeloma.
Academic Article A Phase I Trial of High-Dose Lenalidomide and Melphalan as Conditioning for Autologous Stem Cell Transplantation in Relapsed or Refractory Multiple Myeloma.
Academic Article Monoclonal Antibodies in Multiple Myeloma: A New Wave of the Future.
Academic Article Cellular Proliferation by Multiplex Immunohistochemistry Identifies High-Risk Multiple Myeloma in Newly Diagnosed, Treatment-Naive Patients.
Academic Article Cellular proliferation by multiplex immunohistochemistry identifies aggressive disease behavior in relapsed multiple myeloma.
Academic Article Phase II study of carfilzomib and dexamethasone therapy for newly diagnosed multiple myeloma.
Academic Article Phase 2 study of clarithromycin, pomalidomide, and dexamethasone in relapsed or refractory multiple myeloma.
Academic Article Measurement of ex vivo resistance to proteasome inhibitors, IMiDs, and daratumumab during multiple myeloma progression.
Academic Article Exploiting Protein Translation Dependence in Multiple Myeloma with Omacetaxine-Based Therapy.
Academic Article Sustained Response to Selinexor-Based Therapy for Triple-Class Refractory Multiple Myeloma with Early Relapse After Allogeneic Stem Cell Transplantation.
Academic Article Carfilzomib and dexamethasone induction with lenalidomide, clarithromycin and dexamethasone consolidation and lenalidomide maintenance for newly diagnosed multiple myeloma.
Academic Article Harnessing the T Cell to Treat Multiple Myeloma: Dawn of a New Therapeutic Paradigm.
Academic Article Lenalidomide-induced autoimmune enteropathy complicating treatment of multiple myeloma with concurrent systemic mastocytosis.
Academic Article Isatuximab in combination with cemiplimab in patients with relapsed/refractory multiple myeloma: A phase 1/2 study.
Academic Article CD38 antibody re-treatment in daratumumab-refractory multiple myeloma after time on other therapies.
Academic Article CD46-ADC Reduces the Engraftment of Multiple Myeloma Patient-Derived Xenografts.

Search Criteria
  • Multiple Myeloma

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)